GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $98.00

GE HealthCare Technologies (NASDAQ:GEHC) had its target price increased by equities researchers at Evercore ISI from $95.00 to $98.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Evercore ISI’s price objective indicates a potential upside of 17.86% from the company’s current price.

Other equities research analysts have also issued reports about the company. Barclays assumed coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. BTIG Research upped their target price on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research report on Wednesday. Bank of America lifted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their target price for the company from $73.00 to $77.00 in a research report on Thursday, January 15th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $92.42.

GE HealthCare Technologies Stock Performance

GEHC stock traded up $0.52 during trading on Thursday, hitting $83.15. 1,757,003 shares of the company’s stock traded hands, compared to its average volume of 3,580,333. The stock has a market capitalization of $37.88 billion, a price-to-earnings ratio of 17.18, a price-to-earnings-growth ratio of 2.38 and a beta of 1.08. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $94.80. The stock has a fifty day moving average price of $82.68 and a two-hundred day moving average price of $77.47. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period in the previous year, the business posted $1.45 EPS. The company’s quarterly revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

Institutional Trading of GE HealthCare Technologies

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Laurel Wealth Advisors LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $26,000. Optima Capital LLC purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $27,000. Montag A & Associates Inc. lifted its holdings in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares during the last quarter. Godsey & Gibb Inc. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $26,000. Finally, E Fund Management Hong Kong Co. Ltd. raised its position in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after acquiring an additional 196 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 results beat — GE HealthCare reported $1.44 EPS and $5.70B revenue, both topping estimates and showing 7.1% revenue growth, supporting investor optimism. GE HealthCare reports fourth quarter and full year 2025 financial results
• Positive Sentiment: FY‑2026 guidance nudges above consensus — GEHC set FY‑26 EPS guidance of $4.95–$5.15 versus a ~$4.93 consensus, which reinforces the beat as more than one quarter of strength. GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices
• Positive Sentiment: Analyst price‑target upgrades — Wells Fargo raised its PT to $97 (overweight) and BTIG lifted its PT to $91 (buy), signaling institutional confidence and creating incremental upside pressure. Benzinga
• Positive Sentiment: Regulatory win for Allia Moveo — FDA and CE clearance for the Allia Moveo mobile C‑arm (AI guidance, compact design) supports product commercialization and future revenue growth. GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut
• Neutral Sentiment: Earnings call & transcript available — Management commentary and the transcript provide more color on growth drivers (Imaging, PDx) and cost items; useful for gauging sustainability of the beat. GE HealthCare Technologies Inc. (GEHC) Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Company materials posted — Press release, slide deck and call recording are available for investors who want the detailed metrics and segment disclosures. GE HealthCare earnings materials
• Negative Sentiment: Margins under pressure — Net margin declined due to tariffs and an unfavorable product mix, a headwind that could cap multiple expansion until costs normalize. GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
• Negative Sentiment: Profit fell year‑over‑year — Coverage noted that GAAP profit declined despite higher revenue, which keeps some investors cautious about near‑term profitability. GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.